05.08.13

IBA Visicoil Successfully Concludes Litigation Over Competing Fiducial Marker

IBA (Ion Beam Applications S.A.), the global high-tech leader in the next generation of radiation therapy and diagnostics for the treatment of cancer, announces the execution of a Letter of Intent to resolve litigation and claims of IBA subsidiary RadioMed Corp. against ONC Solutions, Inc. RadioMed sued ONC for misappropriation of RadioMed’s trade secrets and use of them to develop a competing linear fiducial marker called the X-Mark™...